Our hypothesis is that often undiagnosed and hence, uncorrected insulin resistance in patients with depression contributes to inadequate patient response to standard antidepressants and that adjunctive therapy with insulin sensitivity-enhancing lifestyle and dietary-related interventions may improve treatment response through correction of underlying insulin resistance. This evidence concerns the gene INS and Insulin resistance.